ライフサイエンスコーパス: Lambert

1 Lambert Eaton myasthenic syndrome and acquired neuromyot

2 Lambert et al. make clever use of psoriasis patient gene

3 Lambert et al. reported that silicate ions catalyze the

4 Lambert-Eaton myasthenic syndrome (LEMS) is a paraneopla

5 Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmun

6 Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmun

7 Lambert-Eaton myasthenic syndrome IgG did not selectivel

8 mplitudes were correlated with decibel and 1/Lambert DLS for the central 18 degrees of the visual fie

9 ensitivities (both in logarithmic [dB] and 1/Lambert scales [1/L]), were investigated with components

10 There was a linear correlation between 1/Lambert DLS and PERG amplitude (transient PERG: R(2) = 0

11 im area, and a linear relationship between 1/Lambert DLS and PERG amplitude and neuroretinal rim area

12 There was a linear correlation between 1/Lambert DLS and temporal neuroretinal rim area (R(2) = 0

13 .75%, and -0.78% per year for decibel DLS, 1/Lambert DLS, transient PERG, and SS PERG, respectively.

14 The decibel is 10. log(1/Lambert), where the Lambert is the unit of test spot int

15 The RS values were converted to 1/Lambert.

16 limbic encephalitis, 3 cerebellar ataxia, 2 Lambert-Eaton myasthenic syndrome, 1 autonomic neuropath

17 ataxia type 2, spinocerebellar ataxia 6, and Lambert-Eaton myasthenic syndrome), and the skeletal mus

18 ption of the opsoclonus-myoclonus ataxia and Lambert-Eaton myasthenic syndromes.

19 ome, dermatomyositis, myasthenia gravis, and Lambert-Eaton myasthenic syndrome.

20 Some syndromes such as Lambert-Eaton myasthenic syndrome and neuromyotonia are

21 t underlie muscle weakness in the autoimmune Lambert-Eaton myasthenic syndrome (LEMS).

22 tonomic symptoms characterize the autoimmune Lambert-Eaton myasthenic syndrome (LEMS).

23 microscopic optical path lengths, both Beer-Lambert's law and the law of superposition were found to

24 e obtained, quantitatively obeying both Beer-Lambert's law and the law of superposition, despite the

25 Quantitative analysis is governed by Beer-Lambert Law relationships.

26 on in the ITO, causing a deviation from Beer-Lambert absorption that results in an optimum ITO thickn

27 ted with wavelength-dependent, modified Beer-Lambert Law.

28 on plots are assessed in the context of Beer-Lambert's law and provide combined with time-dependent d

29 optically thick conditions, given that Beer-Lambert's law is valid.

30 in coincide with those predicted by the Beer-Lambert law for a range of ferricyanide concentrations f

31 The Beer-Lambert law is obeyed by both porphyrin forms.

32 related to platinum concentration (the Beer-Lambert Law).

33 ography (SXCMT) and an extension of the Beer-Lambert law.

34 coefficient (epsilon) and applying the Beer-Lambert law.

35 e observed absorbances deviate from the Beer-Lambert law.

36 s developed electrophysiologically confirmed Lambert-Eaton myasthenic syndrome.

37 ved in the autoimmune neuromuscular disorder Lambert-Eaton myasthenic syndrome.

38 e characteristic of the autoimmune disorder, Lambert-Eaton syndrome (LES).

39 ved in an autoimmune neuromuscular disorder, Lambert-Eaton myasthenic syndrome.

40 uropathy, movement disorder, encephalopathy, Lambert-Eaton syndrome, and seizures.

41 o coimmunogenic tumor antigens, for example, Lambert-Eaton syndrome (P/Q-type Ca(2+) channel antibody

42 ation patients without clinically identified Lambert-Eaton myasthenic syndrome had P/Q-type voltage-g

43 lastic cerebellar degeneration, but improved Lambert-Eaton myasthenic syndrome symptoms.

44 In Lambert-Eaton myasthenic syndrome (LEMS), SOX antibodies

45 iated with small-cell lung cancer, including Lambert-Eaton myasthenic syndrome (LEMS) and paraneoplas

46 Swiss Jim Lambert (SJL) and Friend Virus B (FVB) mice progressivel

47 ciated with Waldenstrom's macroglobulinemia, Lambert-Eaton myasthenic syndrome, and multifocal motor

48 d/or signs were present in 18 of 23 (78%) of Lambert-Eaton myasthenic syndrome (LEMS) patients evalua

49 d GV-58 in a passive transfer mouse model of Lambert-Eaton myasthenic syndrome and have shown that we

50 euromuscular diseases myasthenic syndrome of Lambert-Eaton and botulism.

51 t, some PNSs such as sensory neuronopathy or Lambert-Eaton myasthenic syndrome rarely occur in lympho

52 c neuromuscular junction disorder resembling Lambert-Eaton myasthenic syndrome.

53 syn I, DeMarini DM, Caldwell JC, Kavlock RJ, Lambert P, Hecht SS, Bucher JR, Stewart BW, Baan R, Cogl

54 Previous work has demonstrated that Lambert-Eaton syndrome (LES) antibodies reduce calcium c

55 The Lambert-Beer's law was obeyed in the range of 0.07-3.0 m

56 diseases, such as diabetes mellitus and the Lambert-Eaton myasthenic syndrome.

57 Some disorders, such as the Lambert-Eaton myasthenic syndrome, are effectively treat

58 and demonstrated an autoimmune basis for the Lambert Eaton myasthenic syndrome and 'seronegative' mya

59 ubtype that is targeted by antibodies in the Lambert-Eaton myasthenic syndrome has been identified, a

60 The decibel is 10. log(1/Lambert), where the Lambert is the unit of test spot intensity.

61 ced improvement in several patients with the Lambert-Eaton myasthenic syndrome and myasthenia gravis

62 ion sometimes occurs in association with the Lambert-Eaton myasthenic syndrome.

63 a were recorded and epsilon calculated using Lambert-Beer's law.

64 ls of gabapentin funded by Pfizer and Warner-Lambert's subsidiary, Parke-Davis (hereafter referred to

65 thenic syndrome and have shown that weakened Lambert-Eaton myasthenic syndrome-model neuromuscular sy

66 ample, P/Q-type Ca(2+)-channel antibody with Lambert-Eaton syndrome (n = 5), anti-neuronal nuclear an

67 Incubation of cells with Lambert-Eaton myasthenic syndrome IgG for 24 to 48 hours